HomeBUSINESS
BUSINESS

Poxel Eyeing Japan as 1st Market for Its Lead Diabetes Candidate: CEO
(Feb.6.2018)

Poxel CEO Thomas Kuhn
French biopharma Poxel is looking at Japan as the world’s first market to debut its lead diabetes drug candidate imeglimin as it hopes to capitalize on its collaboration with local partner Sumitomo Dainippon Pharma, CEO Thomas Kuhn told Jiho in a Tokyo interview ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar